CALML3 and psoriasis: To experimental validate the immunoregulatory potential of cell-type specific lncRNAs, we selected three lncRNAs (SNHG9, CALML3-AS1, and CARMN), and in silico examined their expression levels in different cell clusters under healthy and psoriasis conditions (Figures 3A, B).